Wells Fargo’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $313M | Sell |
|
|||||
|
2025
Q1 | $342M | Buy |
|
|||||
|
2024
Q4 | $278M | Sell |
|
|||||
|
2024
Q3 | $386M | Buy |
|
|||||
|
2024
Q2 | $384M | Buy |
|
|||||
|
2024
Q1 | $321M | Buy |
|
|||||
|
2023
Q4 | $305M | Sell |
|
|||||
|
2023
Q3 | $271M | Sell |
|
|||||
|
2023
Q2 | $284M | Buy |
|
|||||
|
2023
Q1 | $246M | Buy |
|
|||||
|
2022
Q4 | $216M | Sell |
|
|||||
|
2022
Q3 | $225M | Sell |
|
|||||
|
2022
Q2 | $225M | Sell |
|
|||||
|
2022
Q1 | $222M | Buy |
|
|||||
|
2021
Q4 | $186M | Sell |
|
|||||
|
2021
Q3 | $205M | Sell |
|
|||||
|
2021
Q2 | $237M | Sell |
|
|||||
|
2021
Q1 | $264M | Sell |
|
|||||
|
2020
Q4 | $308M | Sell |
|
|||||
|
2020
Q3 | $401M | Sell |
|
|||||
|
2020
Q2 | $443M | Buy |
|
|||||
|
2020
Q1 | $319M | Buy |
|
|||||
|
2019
Q4 | $290M | Sell |
|
|||||
|
2019
Q3 | $232M | Sell |
|
|||||
|
2019
Q2 | $272M | Sell |
|
|||||
|
2019
Q1 | $290M | Sell |
|
|||||
|
2018
Q4 | $317M | Sell |
|
|||||
|
2018
Q3 | $415M | Buy |
|
|||||
|
2018
Q2 | $355M | Buy |
|
|||||
|
2018
Q1 | $327M | Sell |
|
|||||
|
2017
Q4 | $319M | Buy |
|
|||||
|
2017
Q3 | $301M | Buy |
|
|||||
|
2017
Q2 | $247M | Buy |
|
|||||
|
2017
Q1 | $200M | Buy |
|
|||||
|
2016
Q4 | $113M | Sell |
|
|||||
|
2016
Q3 | $143M | Sell |
|
|||||
|
2016
Q2 | $157M | Sell |
|
|||||
|
2016
Q1 | $157M | Sell |
|
|||||
|
2015
Q4 | $329M | Buy |
|
|||||
|
2015
Q3 | $122M | Sell |
|
|||||
|
2015
Q2 | $157M | Sell |
|
|||||
|
2015
Q1 | $153M | Sell |
|
|||||
|
2014
Q4 | $198M | Buy |
|
|||||
|
2014
Q3 | $145M | Buy |
|
|||||
|
2014
Q2 | $63.7M | Sell |
|
|||||
|
2014
Q1 | $122M | Sell |
|
|||||
|
2013
Q4 | $162M | Buy |
|
|||||
|
2013
Q3 | $152M | Buy |
|
|||||
|
2013
Q2 | $152M | Buy |
|